Abuse resistant transmucosal drug delivery device

Abstract

The present invention relates to a solid pharmaceutical dosage form for abusable drug delivery with reduced illicit abuse potential. The dosage form is presented as a bioerodable transmucosal delivery device that includes an abusable drug and an antagonist to the abusable drug associated with an abuse-resistant matrix. The devices of the invention may be in the form of a layered film or a tablet. Upon application in a non-abusive manner, the device adheres to the mucosal surface, providing transmucosal drug delivery of the drug with minimal absorption of the antagonist into systemic circulation.

1 . A bioerodable abuse-resistant drug delivery device comprising:
 a transmucosal delivery composition comprising an abusable drug; and an abuse-resistant matrix comprising an antagonist to the abusable drug.   
     
     
         2 - 33 . (canceled)